Breast cancer patient's cell-mediated immune response to thomsen-friedenreich (T) antigen
β Scribed by Georg F. Springer; M. Satya Murthy; Parimal R. Desai; Edward F. Scanlon
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 654 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Thomsen-Friedenreich (T) antigenic specificity as determined with human serum anti-T was found in reactive form in breast adenocarcinomata but not in healthy and generally not in benign breast tissues. T-antigenic specificity was demonstrable in all metastatic breast carcinoma lesions. T specificity was also present in adeno-and squamous cell carcinomata from other organs; it was not found in the four melanomata, one glioblastoma, and seven benign non-breast tumors. Breast carcinoma patients but not healthy people showed cellular immunity to T antigen in vivo and in vitro. Most striking was the delayed-type cutaneous hypersensitivity reaction that was positive in over 85% of the ductal breast carcinoma patients tested, negative in over 94% benign breast disease patients, and in all presumably healthy individuals investigated. T antigen is readily available from healthy human red blood cells in uncontaminated form, and free of HL-A and Australia antigens.
Cancer 45:
π SIMILAR VOLUMES
## Abstract There is increasing evidence that tumors elicit specific Tβcell responses in a substantial proportion of patients. Recently, we have shown that in patients with colorectal cancer specific T cells against the tumorβassociated antigens (TAA) EpβCAM, herβ2/neu or CEA can be detected in per
## Abstract We have investigated the sequential interaction of macrophages, initiator T lymphocytes (ITL) and recruited T lymphocytes (RTL) in the development of a T cellβmediated response to soluble antigens. Macrophages were pulsed with soluble antigens and used to sensitize ITL __in vitro.__ The
## Abstract Screening of a cDNA expression library from a primary breast tumor with the autologous patient serum led to the isolation of 6 cDNA clones corresponding to 3 different genes, including a novel gene that maps to chromosome 1 and encodes the human homologue of mouse Mena (hMena, cDNA clon